Effects of Resistance-Associated NS5A Mutations in Hepatitis C Virus on Viral Production and Susceptibility to Antiviral Reagents-Reference-Cited by-同舟云学术

Effects of Resistance-Associated NS5A Mutations in Hepatitis C Virus on Viral Production and Susceptibility to Antiviral Reagents

Published:2016-10-05 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Nitta Sayuri,Asahina Yasuhiro,Matsuda Mami,Yamada Norie,Sugiyama Ryuichi,Masaki Takahiro,Suzuki Ryosuke,Kato Nobuyuki,Watanabe Mamoru,Wakita Takaji,Kato Takanobu

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep34652.pdf

Reference48 articles.

1. Webster, D. P., Klenerman, P. & Dusheiko, G. M. Hepatitis C. The Lancet 385, 1124–1135, doi: 10.1016/S0140-6736(14)62401-6 (2015).

2. Zoulim, F. et al. Hepatitis C virus treatment in the real world: optimising treatment and access to therapies. Gut 64, 1824–1833, doi: 10.1136/gutjnl-2015-310421 (2015).

3. Pawlotsky, J. M. New Hepatitis C Therapies: The Toolbox, Strategies, and Challenges. Gastroenterology 146, 1176–1192, doi: 10.1053/j.gastro.2014.03.003 (2014).

4. Pawlotsky, J. M. NS5A inhibitors in the treatment of hepatitis C. J Hepatol 59, 375–382, doi: 10.1016/j.jhep.2013.03.030 (2013).

5. Sarrazin, C. The importance of resistance to direct antiviral drugs in HCV infection in clinical practice. Journal of Hepatology 64, 486–504, doi: 10.1016/j.jhep.2015.09.011 (2016).

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Increase in the Prevalence of Clinically Relevant Resistance-Associated Substitutions in Four Direct-Acting Antiviral Regimens: A Study Using GenBank HCV Sequences;Pathogens;2024-08-09

2. Distribution of hepatitis С virus drug resistance mutations among patients with recurrence of the disease during therapy with direct antiviral drugs;HIV Infection and Immunosuppressive Disorders;2024-01-17

3. HCV DRUG RESISTANCE MUTATIONS IN HIV–INFECTED PATIENTS;Russian Journal of Infection and Immunity;2023-10-13

4. First report on molecular docking analysis and drug resistance substitutions to approved HCV NS5A and NS5B inhibitors amongst Iranian patients;BMC Gastroenterology;2021-11-24

5. An in vitro study of an Artocarpus heterophyllus substance as a hepatitis C antiviral and its combination with current anti-HCV drugs;BMC Complementary Medicine and Therapies;2021-10-12